Efficacy of Omalizumab in Indolent Systemic Mastocytosis

BACKGROUND: Systemic mastocytosis (SM) comprises a heterogeneous group of disorders characterized by the proliferation of clonal mast cells in skin and various internal organs. Omalizumab is an established, labelled therapy for allergic asthma and chronic urticaria, but its experience in the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Slapnicar, Calum, Trinkaus, Martina, Hicks, Lisa, Vadas, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766258/
https://www.ncbi.nlm.nih.gov/pubmed/31637065
http://dx.doi.org/10.1155/2019/3787586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766258/
https://www.ncbi.nlm.nih.gov/pubmed/31637065
http://dx.doi.org/10.1155/2019/3787586

Ejemplares similares